1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunochemistry
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global IVD Infectious Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical Laboratories
1.3.3 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global IVD Infectious Diseases Market Perspective (2017-2028)
2.2 IVD Infectious Diseases Growth Trends by Region
2.2.1 IVD Infectious Diseases Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 IVD Infectious Diseases Historic Market Size by Region (2017-2022)
2.2.3 IVD Infectious Diseases Forecasted Market Size by Region (2023-2028)
2.3 IVD Infectious Diseases Market Dynamics
2.3.1 IVD Infectious Diseases Industry Trends
2.3.2 IVD Infectious Diseases Market Drivers
2.3.3 IVD Infectious Diseases Market Challenges
2.3.4 IVD Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Diseases Players by Revenue
3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2017-2022)
3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2017-2022)
3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVD Infectious Diseases Revenue
3.4 Global IVD Infectious Diseases Market Concentration Ratio
3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2021
3.5 IVD Infectious Diseases Key Players Head office and Area Served
3.6 Key Players IVD Infectious Diseases Product Solution and Service
3.7 Date of Enter into IVD Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Diseases Breakdown Data by Type
4.1 Global IVD Infectious Diseases Historic Market Size by Type (2017-2022)
4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2023-2028)
5 IVD Infectious Diseases Breakdown Data by Application
5.1 Global IVD Infectious Diseases Historic Market Size by Application (2017-2022)
5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America IVD Infectious Diseases Market Size (2017-2028)
6.2 North America IVD Infectious Diseases Market Size by Type
6.2.1 North America IVD Infectious Diseases Market Size by Type (2017-2022)
6.2.2 North America IVD Infectious Diseases Market Size by Type (2023-2028)
6.2.3 North America IVD Infectious Diseases Market Share by Type (2017-2028)
6.3 North America IVD Infectious Diseases Market Size by Application
6.3.1 North America IVD Infectious Diseases Market Size by Application (2017-2022)
6.3.2 North America IVD Infectious Diseases Market Size by Application (2023-2028)
6.3.3 North America IVD Infectious Diseases Market Share by Application (2017-2028)
6.4 North America IVD Infectious Diseases Market Size by Country
6.4.1 North America IVD Infectious Diseases Market Size by Country (2017-2022)
6.4.2 North America IVD Infectious Diseases Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe IVD Infectious Diseases Market Size (2017-2028)
7.2 Europe IVD Infectious Diseases Market Size by Type
7.2.1 Europe IVD Infectious Diseases Market Size by Type (2017-2022)
7.2.2 Europe IVD Infectious Diseases Market Size by Type (2023-2028)
7.2.3 Europe IVD Infectious Diseases Market Share by Type (2017-2028)
7.3 Europe IVD Infectious Diseases Market Size by Application
7.3.1 Europe IVD Infectious Diseases Market Size by Application (2017-2022)
7.3.2 Europe IVD Infectious Diseases Market Size by Application (2023-2028)
7.3.3 Europe IVD Infectious Diseases Market Share by Application (2017-2028)
7.4 Europe IVD Infectious Diseases Market Size by Country
7.4.1 Europe IVD Infectious Diseases Market Size by Country (2017-2022)
7.4.2 Europe IVD Infectious Diseases Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Diseases Market Size (2017-2028)
8.2 Asia-Pacific IVD Infectious Diseases Market Size by Type
8.2.1 Asia-Pacific IVD Infectious Diseases Market Size by Type (2017-2022)
8.2.2 Asia-Pacific IVD Infectious Diseases Market Size by Type (2023-2028)
8.2.3 Asia-Pacific IVD Infectious Diseases Market Share by Type (2017-2028)
8.3 Asia-Pacific IVD Infectious Diseases Market Size by Application
8.3.1 Asia-Pacific IVD Infectious Diseases Market Size by Application (2017-2022)
8.3.2 Asia-Pacific IVD Infectious Diseases Market Size by Application (2023-2028)
8.3.3 Asia-Pacific IVD Infectious Diseases Market Share by Application (2017-2028)
8.4 Asia-Pacific IVD Infectious Diseases Market Size by Region
8.4.1 Asia-Pacific IVD Infectious Diseases Market Size by Region (2017-2022)
8.4.2 Asia-Pacific IVD Infectious Diseases Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America IVD Infectious Diseases Market Size (2017-2028)
9.2 Latin America IVD Infectious Diseases Market Size by Type
9.2.1 Latin America IVD Infectious Diseases Market Size by Type (2017-2022)
9.2.2 Latin America IVD Infectious Diseases Market Size by Type (2023-2028)
9.2.3 Latin America IVD Infectious Diseases Market Share by Type (2017-2028)
9.3 Latin America IVD Infectious Diseases Market Size by Application
9.3.1 Latin America IVD Infectious Diseases Market Size by Application (2017-2022)
9.3.2 Latin America IVD Infectious Diseases Market Size by Application (2023-2028)
9.3.3 Latin America IVD Infectious Diseases Market Share by Application (2017-2028)
9.4 Latin America IVD Infectious Diseases Market Size by Country
9.4.1 Latin America IVD Infectious Diseases Market Size by Country (2017-2022)
9.4.2 Latin America IVD Infectious Diseases Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Diseases Market Size (2017-2028)
10.2 Middle East & Africa IVD Infectious Diseases Market Size by Type
10.2.1 Middle East & Africa IVD Infectious Diseases Market Size by Type (2017-2022)
10.2.2 Middle East & Africa IVD Infectious Diseases Market Size by Type (2023-2028)
10.2.3 Middle East & Africa IVD Infectious Diseases Market Share by Type (2017-2028)
10.3 Middle East & Africa IVD Infectious Diseases Market Size by Application
10.3.1 Middle East & Africa IVD Infectious Diseases Market Size by Application (2017-2022)
10.3.2 Middle East & Africa IVD Infectious Diseases Market Size by Application (2023-2028)
10.3.3 Middle East & Africa IVD Infectious Diseases Market Share by Application (2017-2028)
10.4 Middle East & Africa IVD Infectious Diseases Market Size by Country
10.4.1 Middle East & Africa IVD Infectious Diseases Market Size by Country (2017-2022)
10.4.2 Middle East & Africa IVD Infectious Diseases Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD IVD Infectious Diseases Introduction
11.1.4 BD Revenue in IVD Infectious Diseases Business (2017-2022)
11.1.5 BD Recent Developments
11.2 BioMerieux
11.2.1 BioMerieux Company Details
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux IVD Infectious Diseases Introduction
11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2017-2022)
11.2.5 BioMerieux Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott IVD Infectious Diseases Introduction
11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2017-2022)
11.3.5 Abbott Recent Developments
11.4 Quidel
11.4.1 Quidel Company Details
11.4.2 Quidel Business Overview
11.4.3 Quidel IVD Infectious Diseases Introduction
11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2017-2022)
11.4.5 Quidel Recent Developments
11.5 Gen-Probe
11.5.1 Gen-Probe Company Details
11.5.2 Gen-Probe Business Overview
11.5.3 Gen-Probe IVD Infectious Diseases Introduction
11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2017-2022)
11.5.5 Gen-Probe Recent Developments
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott IVD Infectious Diseases Introduction
11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2017-2022)
11.6.5 Abbott Recent Developments
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher IVD Infectious Diseases Introduction
11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2017-2022)
11.7.5 Danaher Recent Developments
11.8 Sysmex
11.8.1 Sysmex Company Details
11.8.2 Sysmex Business Overview
11.8.3 Sysmex IVD Infectious Diseases Introduction
11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2017-2022)
11.8.5 Sysmex Recent Developments
11.9 Orasure
11.9.1 Orasure Company Details
11.9.2 Orasure Business Overview
11.9.3 Orasure IVD Infectious Diseases Introduction
11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2017-2022)
11.9.5 Orasure Recent Developments
11.10 Hologic
11.10.1 Hologic Company Details
11.10.2 Hologic Business Overview
11.10.3 Hologic IVD Infectious Diseases Introduction
11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2017-2022)
11.10.5 Hologic Recent Developments
11.11 Cepheid
11.11.1 Cepheid Company Details
11.11.2 Cepheid Business Overview
11.11.3 Cepheid IVD Infectious Diseases Introduction
11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2017-2022)
11.11.5 Cepheid Recent Developments
11.12 Qiagen
11.12.1 Qiagen Company Details
11.12.2 Qiagen Business Overview
11.12.3 Qiagen IVD Infectious Diseases Introduction
11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2017-2022)
11.12.5 Qiagen Recent Developments
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Details
11.13.2 Roche Diagnostics Business Overview
11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction
11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2017-2022)
11.13.5 Roche Diagnostics Recent Developments
11.14 Siemens Healthcare
11.14.1 Siemens Healthcare Company Details
11.14.2 Siemens Healthcare Business Overview
11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction
11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2017-2022)
11.14.5 Siemens Healthcare Recent Developments
11.15 Bio-Rad Laboratories
11.15.1 Bio-Rad Laboratories Company Details
11.15.2 Bio-Rad Laboratories Business Overview
11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction
11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2017-2022)
11.15.5 Bio-Rad Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Immunochemistry
Table 3. Key Players of Molecular Diagnostics
Table 4. Global IVD Infectious Diseases Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global IVD Infectious Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global IVD Infectious Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global IVD Infectious Diseases Market Share by Region (2017-2022)
Table 8. Global IVD Infectious Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global IVD Infectious Diseases Market Share by Region (2023-2028)
Table 10. IVD Infectious Diseases Market Trends
Table 11. IVD Infectious Diseases Market Drivers
Table 12. IVD Infectious Diseases Market Challenges
Table 13. IVD Infectious Diseases Market Restraints
Table 14. Global IVD Infectious Diseases Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global IVD Infectious Diseases Revenue Share by Players (2017-2022)
Table 16. Global Top IVD Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2021)
Table 17. Ranking of Global Top IVD Infectious Diseases Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by IVD Infectious Diseases Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players IVD Infectious Diseases Product Solution and Service
Table 21. Date of Enter into IVD Infectious Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global IVD Infectious Diseases Revenue Market Share by Type (2017-2022)
Table 25. Global IVD Infectious Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global IVD Infectious Diseases Revenue Market Share by Type (2023-2028)
Table 27. Global IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global IVD Infectious Diseases Revenue Share by Application (2017-2022)
Table 29. Global IVD Infectious Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global IVD Infectious Diseases Revenue Share by Application (2023-2028)
Table 31. North America IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America IVD Infectious Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America IVD Infectious Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe IVD Infectious Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe IVD Infectious Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific IVD Infectious Diseases Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific IVD Infectious Diseases Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America IVD Infectious Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America IVD Infectious Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa IVD Infectious Diseases Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa IVD Infectious Diseases Market Size by Country (2023-2028) & (US$ Million)
Table 61. BD Company Details
Table 62. BD Business Overview
Table 63. BD IVD Infectious Diseases Product
Table 64. BD Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 65. BD Recent Developments
Table 66. BioMerieux Company Details
Table 67. BioMerieux Business Overview
Table 68. BioMerieux IVD Infectious Diseases Product
Table 69. BioMerieux Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 70. BioMerieux Recent Developments
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott IVD Infectious Diseases Product
Table 74. Abbott Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 75. Abbott Recent Developments
Table 76. Quidel Company Details
Table 77. Quidel Business Overview
Table 78. Quidel IVD Infectious Diseases Product
Table 79. Quidel Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 80. Quidel Recent Developments
Table 81. Gen-Probe Company Details
Table 82. Gen-Probe Business Overview
Table 83. Gen-Probe IVD Infectious Diseases Product
Table 84. Gen-Probe Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 85. Gen-Probe Recent Developments
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott IVD Infectious Diseases Product
Table 89. Abbott Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 90. Abbott Recent Developments
Table 91. Danaher Company Details
Table 92. Danaher Business Overview
Table 93. Danaher IVD Infectious Diseases Product
Table 94. Danaher Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 95. Danaher Recent Developments
Table 96. Sysmex Company Details
Table 97. Sysmex Business Overview
Table 98. Sysmex IVD Infectious Diseases Product
Table 99. Sysmex Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 100. Sysmex Recent Developments
Table 101. Orasure Company Details
Table 102. Orasure Business Overview
Table 103. Orasure IVD Infectious Diseases Product
Table 104. Orasure Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 105. Orasure Recent Developments
Table 106. Hologic Company Details
Table 107. Hologic Business Overview
Table 108. Hologic IVD Infectious Diseases Product
Table 109. Hologic Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 110. Hologic Recent Developments
Table 111. Cepheid Company Details
Table 112. Cepheid Business Overview
Table 113. Cepheid IVD Infectious Diseases Product
Table 114. Cepheid Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 115. Cepheid Recent Developments
Table 116. Qiagen Company Details
Table 117. Qiagen Business Overview
Table 118. Qiagen IVD Infectious Diseases Product
Table 119. Qiagen Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 120. Qiagen Recent Developments
Table 121. Roche Diagnostics Company Details
Table 122. Roche Diagnostics Business Overview
Table 123. Roche Diagnostics IVD Infectious Diseases Product
Table 124. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 125. Roche Diagnostics Recent Developments
Table 126. Siemens Healthcare Company Details
Table 127. Siemens Healthcare Business Overview
Table 128. Siemens Healthcare IVD Infectious Diseases Product
Table 129. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 130. Siemens Healthcare Recent Developments
Table 131. Bio-Rad Laboratories Company Details
Table 132. Bio-Rad Laboratories Business Overview
Table 133. Bio-Rad Laboratories IVD Infectious Diseases Product
Table 134. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million)
Table 135. Bio-Rad Laboratories Recent Developments
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Infectious Diseases Market Share by Type: 2021 VS 2028
Figure 2. Immunochemistry Features
Figure 3. Molecular Diagnostics Features
Figure 4. Global IVD Infectious Diseases Market Share by Application: 2021 VS 2028
Figure 5. Clinical Laboratories Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. IVD Infectious Diseases Report Years Considered
Figure 8. Global IVD Infectious Diseases Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global IVD Infectious Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global IVD Infectious Diseases Market Share by Region: 2021 VS 2028
Figure 11. Global IVD Infectious Diseases Market Share by Players in 2021
Figure 12. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2021
Figure 14. North America IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America IVD Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 16. North America IVD Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 17. North America IVD Infectious Diseases Market Size Share by Country (2017-2028)
Figure 18. United States IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe IVD Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 22. Europe IVD Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 23. Europe IVD Infectious Diseases Market Size Share by Country (2017-2028)
Figure 24. Germany IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific IVD Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific IVD Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific IVD Infectious Diseases Market Size Share by Region (2017-2028)
Figure 34. China IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America IVD Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 42. Latin America IVD Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 43. Latin America IVD Infectious Diseases Market Size Share by Country (2017-2028)
Figure 44. Mexico IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa IVD Infectious Diseases Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa IVD Infectious Diseases Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa IVD Infectious Diseases Market Size Share by Country (2017-2028)
Figure 50. Turkey IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. BD Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 54. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 55. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 56. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 57. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 58. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 59. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 60. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 61. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 62. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 63. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 64. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 65. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 66. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 67. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed